Are you Dr. Miller?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 48 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1515 N Campbell Ave
Tucson, AZ 85724Phone+1 520-626-2816Fax+1 520-626-3754
Summary
- Dr. Thomas Miller, MD is an oncologist in Tucson, Arizona. He is currently licensed to practice medicine in Arizona. He is affiliated with Banner - University Medical Center Tucson and is a Professor of Medicine at University Ariz College of Medicine.
Education & Training
University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 1977 - 1980
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1975 - 1977- University of Illinois College of Medicine at ChicagoInternship, Internal Medicine, 1972 - 1973
- University of Illinois College of MedicineClass of 1972
Certifications & Licensure
AZ State Medical License 1980 - 2016
Clinical Trials
- S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma Start of enrollment: 2000 Apr 01
- S0313 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma Start of enrollment: 2004 Feb 01
- Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Stage II, III, or IV Follicular NHL Start of enrollment: 2006 May 15
- Join now to see all
Publications & Presentations
PubMed
- 65 citationsPositron Emission Tomography–Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Stu...Daniel O. Persky, Hongli Li, Deborah M. Stephens, Steven I. Park, Nancy L. Bartlett
Journal of Clinical Oncology. 2020-07-13 - 1 citationsIssues and Opportunities on Implementing an Online Faculty Review System.Brian L. Erstad, Maliaca Oxnam, Thomas P. Miller, JoLaine R. Draugalis
American Journal of Pharmaceutical Education. 2018-04-01 - 65 citationsPhase I study of single-agent CC-292, a highly selective Bruton’s tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemiaJennifer R. Brown, Wael A. Harb, Brian T. Hill, Janice Gabrilove, Jeff P. Sharman
Haematologica. 2016-07-01
Professional Memberships
- Member
